Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Due to Virus C Chronic Hepatitis”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Large-scale testing (Phase 3)Study completedNCT02597166
What this trial is testing

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, ChronicCirrhosis, Decompensated
University Health Network, Toronto 14
Early research (Phase 1)UnknownNCT00832247
What this trial is testing

Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis

Who this might be right for
Liver Cirrhosis Due to Virus C Chronic Hepatitis
Universidade Federal do Rio de Janeiro 15
Not applicableEnded earlyNCT00867243
What this trial is testing

Prediction of Hepatitis C Recurrence in Liver Transplant Recipients

Who this might be right for
Complication of Transplanted LiverHepatitis C, Chronic
Northwestern University 24
Testing effectiveness (Phase 2)Study completedNCT02161952
What this trial is testing

Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Who this might be right for
FibrosisHepatitis C Chronic
University of Guadalajara 150
Not applicableUnknownNCT04191018
What this trial is testing

GastrOesophageal Varices After Sustained Virological Response

Who this might be right for
Liver DiseasesHepatitis C
Oswaldo Cruz Foundation 322
Not applicableEnded earlyNCT01951209
What this trial is testing

Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis

Who this might be right for
Liver CirrhosisChronic Hepatitis C
David E. Kaplan, MD MSc 13
Testing effectiveness (Phase 2)Study completedNCT01888900
What this trial is testing

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Who this might be right for
CirrhosisChronic Hepatitis CHepatitis C+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35